beat rais magnitud top bottom line
revis less bullish past ep growth
moder expect limit multipl expans
rais pt higher ep estim stay equal-
weight see balanc risk/reward
equal-weight rate see balanc risk/reward believ top-
line remain healthi due innov longer product cycl sale
initi advisor total support expect limit margin
gain given expens headwind freight labor near-term invest ep
growth moder multipl expans seem unlik view
noth chang thesi anoth great quarter absolut
term us comp ex calendar shift in-lin market
expect two year stack sequenti acceler sixth
quarter row bp product margin rose driven gain smart
home applianc off-set pressur mobil phone comput
expens well manag deliv bp sg leverag despit
invest specialti labor higher wage net ebit grew top
last year ebit margin expand bp vs bp expect declin
adj ep beat estim
guid miss elev expect rose intra-quart
anticip signific beat rais market grown
accustom howev us comp though guidanc
beat high end market expect addit rais
midpoint ep guidanc mean ep beat
flow telegraph margin pressur greater
invest call concentr
ep estim go multipl come prior result trade
consensu ep follow share price declin today
assum ep estim rise flow higher ep guidanc
would trade ep believ one turn contract
bring multipl line valuat fair given lower ep
growth expect go forward
hardline/broadlin retail unit state america
base consensu methodolog
unless otherwis note metric base modelwar
base consensu methodolog
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
rais price target higher ep model ep
slightli high end guidanc assum
total comp bp gm contract bp sg leverag sg per
sqft growth altogeth predict bp ebit margin eros flattish ebit
growth ex week expect ep increas
vs prior forecast flow higher estim
model total comp flat ebit margin ebit growth
price-to-earnings valuat multipl unchang new price target base
ep estim seem fair line
multipl retail deliv lsd-msd comp msd-hsd ep growth
includ expect go forward
also rais bull/bear valu higher ep estim
observ comp momentum like acceler
first time seven quarter us comp would requir two year
stack acceler ex calendar shift anticip
deceler top-lin ep growth limit multipl expans
look forward learn plan greatcal
relat opportun deal close view creat
valuabl first-mov advantag connect health space expect
internet competitor amzn/googl place greater emphasi time
option yet price stock initi take
million greatcal thought deal
top line continu benefit
among least expens categori killer
valuat
tv service-focus revenu initi
extens cost reduct work provid
model leverag potenti
earn result novemb
risk achiev price
product cycl wane consum
gm compress greater price pressur
price target deriv use histor ebitda price-to-earnings multipl
framework price target repres ep
ebitda multipl roughli in-lin retail
space grow compstore ep low mid singl digit
ep ebitda multipl
ep ebitda multipl
comp slight gm contract bp expens
leverag lead ebit margin msd
hsd ebit growth bp margin expans per year ep
equat ebitda multipl turn higher current
valuat given faster expect ep growth
ep ebitda multipl
ep ebitda multipl
forecast lsd adj ebit growth driven comp
modest ebit margin contract billion share buy-back
two year lift ep growth ep equat
ebitda multipl in-lin hardlin retail deliv similar
ep ebitda multipl
ep ebitda multipl
comp modest ebit dollar declin bp ebit
margin declin next two year led gm compress share buy-back
contribut overal lsd/msd ep growth ep
equat ebitda multipl multipl discount lt averag
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report simeon
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
